BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17988527)

  • 21. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
    Onaca N; Davis GL; Goldstein RM; Jennings LW; Klintmalm GB
    Liver Transpl; 2007 Mar; 13(3):391-9. PubMed ID: 17318865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.
    Ramos E; Lladó L; Serrano T; Figueras A; Lastra R; Torras J; Figueras J; Rafecas A; Fabregat J
    Transplantation; 2006 Sep; 82(6):753-8. PubMed ID: 17006321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.
    Salizzoni M; Romagnoli R; Lupo F; David E; Mirabella S; Cerutti E; Ottobrelli A
    Transplantation; 2003 Sep; 76(5):844-8. PubMed ID: 14501865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
    J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
    Ramacciato G; Mercantini P; Cautero N; Corigliano N; Di Benedetto F; Quintini C; Ercolani G; Varotti G; Ziparo V; Pinna AD
    Ann Surg Oncol; 2005 Apr; 12(4):289-97. PubMed ID: 15827681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of TNM clasification in prognostic evaluation of hepatocelluar carcinoma following surgical resection].
    Zhang Z; Wu M; Shen F
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):293-5. PubMed ID: 11776820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma.
    Plessier A; Codes L; Consigny Y; Sommacale D; Dondero F; Cortes A; Degos F; Brillet PY; Vilgrain V; Paradis V; Belghiti J; Durand F
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S86-90. PubMed ID: 14762846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liver transplantation for the treatment of hepatocellular carcinoma].
    Chen XG; Zhu XD; Li W; Liu Y; Zou WL; Niu YJ; Wu FD; Guan ZJ; Yue Y
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):628-31. PubMed ID: 17236562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
    Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
    Onaca N; Davis GL; Jennings LW; Goldstein RM; Klintmalm GB
    Liver Transpl; 2009 Jun; 15(6):574-80. PubMed ID: 19479800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
    Pawlik TM; Delman KA; Vauthey JN; Nagorney DM; Ng IO; Ikai I; Yamaoka Y; Belghiti J; Lauwers GY; Poon RT; Abdalla EK
    Liver Transpl; 2005 Sep; 11(9):1086-92. PubMed ID: 16123959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.